Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885825 | ISIN: US4525253062 | Ticker-Symbol: IUL
Frankfurt
27.06.25 | 08:00
5,650 Euro
+8,65 % +0,450
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUCELL CORPORATION Chart 1 Jahr
5-Tage-Chart
IMMUCELL CORPORATION 5-Tage-Chart

Aktuelle News zur IMMUCELL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiIMMUCELL CORP /DE/ - 8-K, Current Report1
MiImmuCell initiates CEO succession search ahead of planned 2026 retirement1
17.06.IMMUCELL CORP /DE/ - 8-K, Current Report1
05.06.ImmuCell Corporation: ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders1
14.05.ImmuCell Q2 2025 slides: sales momentum continues as Re-Tain awaits FDA approval1
14.05.ImmuCell GAAP EPS of $0.161
12.05.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 20251
IMMUCELL Aktie jetzt für 0€ handeln
08.04.ImmuCell reports record sales in first quarter of 20251
08.04.ImmuCell verzeichnet Rekordumsatz im ersten Quartal 20252
08.04.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025418PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
07.04.IMMUCELL CORP /DE/ - 8-K, Current Report1
07.04.ImmuCell Hires Timothy Fiori As CFO-
07.04.ImmuCell appoints new CFO to bolster growth strategy1
07.04.ImmuCell Corporation: ImmuCell Hires Chief Financial Officer134PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
02.04.ImmuCell Corporation: ImmuCell Announces Initiation of Investigational Product Use of Re-Tain112PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
28.03.IMMUCELL CORP /DE/ - 10-K, Annual Report3
25.02.ImmuCell GAAP EPS of $0.06, revenue of $7.75M1
25.02.ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024142PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
25.02.IMMUCELL CORP /DE/ - 8-K, Current Report-
20.02.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 20241
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1